Literature DB >> 66191

Radioimmunoassay of the WZ polymorphic antigens of normal human colon and their relationship with ABH antigenic determinants.

R Oriol, M Rousset, A Zweibaum, A M Dalix, G Chevalier, E Dussaulx, G Strecker.   

Abstract

Heat resistant, high mol. wt glycoproteins of the three WZ phenotypes (W+Z+, W-Z+ and W-Z-) were extracted from normal human colonic mucosa and labelled with 125I. More than 80 per cent of the radioactivity of the W+Z+ antigens labelled with I125, was precipitated by natural or immune anti-W antibodies. About 60 per cent of the W-Z+ 125I-labelled antigens were precipitated by immune anti-Z antibodies. No specific precipitation could be detected with W-Z- 125I-labelled antigens. All the precipitin reactions were quantitatively inhibited with the crude antigen extracts of the corresponding phenotypes. The W and Z antigens were only found in the intestinal mucosa and there was a 100-fold increase in the relative concentrations between the small bowel and the rectum. As opposed to this, the ABH antigens were found in all the digestive secretions studied, except those of the rectum, and their relative concentrations progressively decreased by about 100 between the small intestine and the recutm. The decrease in ABH concentration seems to be correlated to a WZ increase in the same regions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66191      PMCID: PMC1445211     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Purification, 125I labeling, and immunochemical study of the canine secretory alloantigens (CSA).

Authors:  M Rousset; C Oriol; A Zweibaum; G Chevalier; A M Dalix; E Dussaulx; R Oriol
Journal:  Transplant Proc       Date:  1975-12       Impact factor: 1.066

2.  [Distribution of blood-group substances in human tissues].

Authors:  L E GLYNN; E J HOLBOROW
Journal:  Br Med Bull       Date:  1959-05       Impact factor: 4.291

3.  The influence of the A-like substance of rabbits on their immune response to human blood-group A-substance.

Authors:  L E GLYNN; E J HOLBOROW; G D JOHNSON
Journal:  J Immunol       Date:  1956-05       Impact factor: 5.422

4.  Determination of the structure of the immunodominant groups of the canine secretory alloantigens (CSA) by radioimmunoassay.

Authors:  R Oriol; G Strecker; M Rousset; G Chevalier; A M Dalix; E Dussaulx; A Zweibaum
Journal:  Transplant Proc       Date:  1975-12       Impact factor: 1.066

5.  Studies on canine secretory alloantigens (CSA).

Authors:  A Zweibaum; R Oriol; N Feingold; E Dussaulx; M Rousset; G Chevalier
Journal:  Tissue Antigens       Date:  1974

6.  Radioimmunoassay and saturation analysis. Preparation and assessment of radioactive tracers.

Authors:  W M Hunter
Journal:  Br Med Bull       Date:  1974-01       Impact factor: 4.291

7.  Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.

Authors:  W D Creighton; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

8.  [Demonstration of oligosaccharidosuria associated with various meliturias, and determination of the structure of the oligosaccharides excreted. Hypothesis concerning the origins of oligosaccharides in biological fluids].

Authors:  G Strecker; C Trentesaux-Chauvet; T Riazi-Farzad; B Fournet; S Bouquelet; J Montreuil
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1973-10-15

9.  [Isolation and structural study of 16 oligosaccharides isolated from human urine].

Authors:  G Strecker; J Montruil
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1973-10-08

10.  The histological distribution of blood group substances A and B in man.

Authors:  A E SZULMAN
Journal:  J Exp Med       Date:  1960-06-01       Impact factor: 14.307

View more
  1 in total

1.  Differences in the maturation of the immune response of A- and A+ rabbits. Good and poor responders respectively for the A antigen.

Authors:  R Oriol; A M Dalix
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.